LnRiLWhlYWRpbmcuaGFzLWJhY2tncm91bmR7cGFkZGluZzowfQ==
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
- Cosmetic Dermatology
- Medical Dermatology
- Actinic Keratoses
- Alopecia Areata
- Athlete’s Foot
- Bullous Pemphigoid
- Cysts
- Excessive Perspiration
- Hair Loss
- Hives
- Impetigo
- Ingrown Hairs / Folliculitis
- Keratosis Pilaris
- Lichen Planus
- Lumps, Bumps and Moles
- Lupus
- Melanoma
- Melasma
- Nail Disorders
- Poison Ivy
- Psoriasis
- Rashes
- Rosacea
- Seborrheic Keratosis
- Shingles (Herpes Zoster)
- Skin Cancer
- Vitiligo (Skin Pigment Disorders)
- Warts
- Pediatric Dermatology
- Phototherapy (Light Therapy)
- Surgical and Procedural Dermatology
Moles (suspicious)
“Suspicious moles” typically refer to moles that exhibit characteristics that may indicate a risk of skin cancer, particularly melanoma. Melanoma is a type of skin cancer that can develop from abnormal growth of melanocytes, the pigment-producing cells in the skin.
Some features of moles that may raise suspicion for melanoma include:
- Asymmetry: One half of the mole does not match the other half.
- Irregular Borders: The edges of the mole are not smooth and have irregular, jagged, or blurred borders.
- Varied Colors: The mole has multiple colors or shades, such as brown, black, red, white, or blue.
- Large Diameter: The diameter of the mole is larger than the size of a pencil eraser (about 6 millimeters or 1/4 inch) or is growing in size.
- Evolution: The mole is changing in size, shape, color, or elevation over time, or it looks different from other moles on the body.
- Symptoms: The mole is accompanied by symptoms such as itching, tenderness, pain, or bleeding.
Signature Dermatology
Referring Physicians
Please Fax:
(972) 521-3240